Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

被引:0
|
作者
Negoro, Kenji
Yamano, Yukio
Fushimi, Kazuaki
Saito, Kengo
Nakatani, Ken
Shiiba, Masashi
Yokoe, Hidetaka
Bukawa, Hiroki
Uzawa, Katsuhiro
Wada, Takeshi
Tanzawa, Hideki
Fujita, Shigeyuki
机构
[1] Chiba Univ, Dept Biol Mol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Ctr Excellence Program 21st Century, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[3] Wakayama Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Wakayama, Japan
[4] Chiba Univ Hosp, Div Oral & Maxillofcial Surg, Chiba, Japan
关键词
cisplatin; drug resistance; MTT assay; microarray; pathway analysis; COMBINATION CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; COLORIMETRIC ASSAY; CANCER-PATIENTS; OVARIAN-CANCER; LUNG-CANCER; HEAD; NECK; GENE; CHEMOSENSITIVITY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the mechanism of the resistance to cisplatin (CDDP), we established the CDDP-resistant cell line, KB-R, from CDDP-sensitive oral carcinoma cell line, KB. The 3-(3, 4-dimethyl-thiazol-2-yl) 2, 5-diphenyltetrazolium bromide (MTT) assay indicated that KB-R is 5.5-fold more resistant to CDDP than KB. Microarray analysis indicated that the expression levels of 1,718 genes were elevated at least fivefold or more in KB-R, compared with KB. The expression status of ATP binding cassette (ABC) transporter genes, which belong to multi-drug resistance genes, was confirmed by semi-quantitative reverse transcriptase-polymerase chain reaction and real-time PCR. MRP1 and MRP2 were up-regulated, whereas MDR1 was down-regulated. Pathway and ontology analysis using the Ingenuity Pathway Analysis tool indicated three highly significant genetic networks including 105 of the 1,718 overexpressed genes and one network including 35 'cell-to-cell signaling and interaction' related genes. Our results suggested that these cell lines, KB and KB-R, may be useful for searching the candidate genes responsible for CDDP-resistance and for further study to understand the mechanism of CDDP-resistance.
引用
收藏
页码:1325 / 1332
页数:8
相关论文
共 50 条
  • [21] Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it
    Zhang, Gehou
    Tan, Guolin
    Li, Tieqi
    Ai, Jingang
    Song, Yexun
    Zhou, Zheng
    Xiao, Jian
    Li, Wei
    PEERJ, 2021, 9
  • [22] Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol
    Bible, KC
    Boerner, SA
    Kirkland, K
    Anderl, KL
    Bartelt, D
    Svingen, PA
    Kottke, TJ
    Lee, YK
    Eckdahl, S
    Stalboerger, PG
    Jenkins, RB
    Kaufmann, SH
    CLINICAL CANCER RESEARCH, 2000, 6 (02) : 661 - 670
  • [23] Establishment and characterization of a human parathyroid carcinoma derived cell line
    Gogusev, Jean
    Murakami, Ichiro
    Telvi, Louise
    Goguin, Alexandre
    Sarfati, Emile
    Jaubert, Francis
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (04) : 332 - 340
  • [24] STUDIES ON VARIABILITY OF KB CELL LINE
    HIGGINS, ML
    TILLMAN, MC
    LEACH, KK
    MELNYKOVYCH, G
    LEACH, FR
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1969, 27 (04) : 1013 - +
  • [25] Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma
    Kaur, J
    Ralhan, R
    ORAL ONCOLOGY, 2003, 39 (08) : 806 - 820
  • [26] Establishment and characterization of cisplatin-resistant cell lines from canine mammary gland tumors
    Hu, Mengxin
    Li, Jie
    Fu, Yunwei
    Xu, Enshuang
    Li, Ding
    Huang, Siqi
    Tong, Danning
    Jin, Shengzi
    Guan, Tongxu
    Liu, Yun
    THERIOGENOLOGY, 2024, 217 : 103 - 112
  • [27] Evaluation of the Cytotoxic Activity of Crocin and Safranal, Constituents of Saffron, in Oral Squamous Cell Carcinoma (KB Cell Line)
    Jabini, Raheleh
    Ehtesham-Gharaee, Melika
    Dalirsani, Zohreh
    Mosaffa, Fatemeh
    Delavarian, Zahra
    Behravan, Javad
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2017, 69 (06): : 911 - 919
  • [28] Photodynamic therapy for newly established human squamous cell carcinoma cell line and its cisplatin-resistant subline
    Ikeda, H
    Nonaka, M
    Fujisawa, A
    Shibahara, K
    Inokuchi, T
    LASERS IN DENTISTRY, PROCEEDINGS: REVOLUTION OF DENTAL TREATMENT IN THE NEW MILLENNIUM, 2003, 1248 : 419 - 424
  • [29] Establishment of Cisplatin-Resistant Ovarian Yolk Sac Tumor Cells and Investigation of the Mechanism of Cisplatin Resistance Using This Cell Line
    Shibata, Kiyosumi
    Umezu, Tomokazu
    Sakurai, Maiko
    Kajiyama, Hiroaki
    Yamamoto, Eiko
    Ino, Kazuhiko
    Nawa, Akihiro
    Kikkawa, Fumitaka
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 71 (02) : 104 - 111
  • [30] CHARACTERIZATION OF HIGH-LEVEL CISPLATIN-RESISTANT CELL-LINES ESTABLISHED FROM A HUMAN HEPATOMA-CELL LINE AND HUMAN KB ADENOCARCINOMA CELLS - CROSS-RESISTANCE AND PROTEIN-CHANGES
    SHEN, DW
    AKIYAMA, S
    SCHOENLEIN, P
    PASTAN, I
    GOTTESMAN, MM
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 676 - 683